Replies to post #69531 on Biotech Values

[DewDiligence]

MNTA’s Chairman, James Sulat, is now CEO of Maxygen:

http://finance.yahoo.com/news/Maxygen-Announces-Management-bw-2077134089.html?x=0&.v=1

I don’t see a conflict of interest between what MAXY is doing and what MNTA is doing; however, I would not be surprised if MNTA named another of its independent directors to be Chairman.